Humera KAUSAR, Sana GULL, Waqar AHMAD, Sana Javaid AWAN, Muhammad Tahir SARWAR, Bushra IJAZ, Sultan ASAD, Sajida HASSAN, Muhammad ANSAR

Role of alternative phosphorylation and O-glycosylation of erythropoietin receptor in modulating its function: an in silico study

Detailed knowledge of the three-dimensional (3D) structure of a protein is essential for the proper understanding of its function(s) that could be modified through posttranslational modifications (PTMs). Among these PTMs, alterations of serine/threonine residues of a protein through phosphorylation and O-glycosylation are extremely dynamic and could modulate the functions of a protein by affecting their 3D structure. Potential of a protein for certain PTMs could be evaluated through computer-based methods. Erythropoietin (EPO) is a multifunctional protein that primarily regulates red blood cell production and is also involved in other nonhematopoietic functions; for example, EPO also has cardioprotective and neuroprotective effects. In this study, multifunctional EPO behavior has been revealed based on transient modifications of its receptor. In this study, PTMs of erythropoietin receptor (EPO-R) were predicted using neural network tools, and the possible effects of these modifications are suggested. Phosphorylation and O-glycosylation at serine 380 and 444 of the cytoplasmic domain of EPO-R seem to have an antagonistic role in controlling signaling events induced by EPO. O-glycosylation at threonine 423 might hinder β-TrCP (a ubiquitin ligase) binding, which ubiquitinates at K 428, and ultimately results in the recycling of EPO-R, thus increasing EPO sensitivity. In contrast, the phosphorylated form of the same residue inhibits the recycling of EPO-R and thereby decreases the EPO sensitivity. Additionally, the interplay of O-glycosylation modification at serine 478 and phosphorylation at tyrosine 479 might help in controlling the duration of EPO-induced signaling.

PDF

___

Ande SR, Moulik S, Mishra S (2009). Interaction between O-GlcNAc modification and tyrosine phosphorylation of prohibitin: implication for a novel binary switch. PLOS ONE 4: e4586.
Attwood TK (2000). The quest to deduce protein function from sequence: the role of pattern databases. Int J Biochem Cell Biol 32: 139-155.
Bazan JF (1991). Neuropoietic cytokines in the hematopoietic fold. Neuron 7: 197-208.
Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET, Petit E (1999). A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 19: 643-651.
Bork P, Koonin EV (1998). Predicting functions from protein sequenceswhere are the bottlenecks? Nat Genet 18: 313-318.
Calvillo L, Latini R, Kajstura J, Leri A, Anversa P, Ghezzi P, Salio M, Cerami A, Brines M (2003). Recombinant human erythropoietin protects the myocardium from ischemiareperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci USA 100: 4802-4806.
Cheng X, Hart GW (2001). Alternative O-glycosylation/Ophosphorylation of serine-16 in murine estrogen receptor beta: post-translational regulation of turnover and transactivation activity. J Biol Chem 276: 10570-10575.
Chou TY, Hart GW, Dang CV (1995). c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas. J Biol Chem 270: 18961-18965.
Constantinescu SN, Ghaffari S, Lodish HF (1999). The erythropoietin receptor: Structure, activation and intracellular signal transduction. TEM 10: 18-23.
Dame C, Bartmann P, Wolber E, Fahnenstich H, Hofmann D, Fandrey J (2000). Erythropoietin gene expression in different areas of the developing human central nervous system. Brain Res Dev Brain Res 125: 69-74.
DAndrea AD, Yoshimura A, Youssoufian H, Zon LI, Koo JW, Lodish HF (1991). The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains. Mol Cell Biol 11: 1980-1987.
Digicaylioglu M, Lipton SA (2001). Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NFkappaB signalling cascades. Nature 412: 641-647.
Droit A, Poirier GG, Hunter JM (2005). Experimental and bioinformatic approaches for interrogating protein-protein interactions to determine protein function. J Mol Endocrinol 34: 263-280.
Elliott S, Busse L, Bass MB, Lu H, Sarosi I, Sinclair AM, Spahr C, Um M, Van G, Begley CG (2006). Anti-Epo receptor antibodies do not predict Epo receptor expression. Blood 107: 1892-1895.
Farrell F, Lee A (2004). The erythropoietin receptor and its expression in tumor cells and other tissues. Oncologist 9 Suppl 5: 18-30.
Funakoshi-Tago M, Moriwaki T, Ueda F, Tamura H, Kasahara T, Tago K (2016). Phosphorylated CIS suppresses the Epo or JAK2 V617F mutant-triggered cell proliferation through binding to EpoR. Cell Signal 31: 41-57.
Gross AW, Lodish HF (2006). Cellular trafficking and degradation of erythropoietin and novel erythropoiesis stimulating protein (NESP). J Biol Chem 281: 2024-2032.
Gupta R, Jung E, Gooley AA, Williams KL, Brunak S, Hansen J (1999). Scanning the available Dictyostelium discoideum proteome for O-linked GlcNAc glycosylation sites using neural networks. Glycobiology 9: 1009-1022.
Hu MC, Shi M, Cho HJ, Zhang J, Pavlenco A, Liu S, Sidhu S, Huang LJ, Moe OW (2013). The erythropoietin receptor is a downstream effector of Klotho-induced cytoprotection. Kidney Int 84: 468- 481.
Huang HD, Lee TY, Tzeng SW, Horng JT (2005). KinasePhos: a web tool for identifying protein kinase-specific phosphorylation sites. Nucleic Acids Res 33: W226-229.
Jahangir Z, Ahmad W, Shabbiri K (2014). Alternate phosphorylation/ O-GlcNAc modification on human insulin IRSs: A road towards impaired insulin signaling in Alzheimer and diabetes. Adv Bioinformatics 2014: 324753.
Jelkmann W (1992a). Erythropoietin: structure, control of production, and function. Physiol Rev 72: 449-489.
Jelkmann W (2011b). Regulation of erythropoietin production. Journal Physiol 589: 1251-1258.
Kamemura K, Hayes BK, Comer FI, Hart GW (2002). Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: alternative glycosylation/ phosphorylation of THR-58, a known mutational hot spot of c-Myc in lymphomas, is regulated by mitogens. J Biol Chem 277: 19229-19235.
Klingmuller U (1997). The role of tyrosine phosphorylation in proliferation and maturation of erythroid progenitor cells- -signals emanating from the erythropoietin receptor. Eur J Biochem 249: 637-647.
Klingmuller U, Wu H, Hsiao JG, Toker A, Duckworth BC, Cantley LC, Lodish HF (1997). Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. Proc Natl Acad Sci USA 94: 3016-3021.
Kreegipuu A, Blom N, Brunak S (1999). PhosphoBase, a database of phosphorylation sites: release 2.0. Nucleic Acids Res 27: 237- 239.
Lodish HF, Hilton DJ, Klingmuller U, Watowich SS, Wu H (1995). The erythropoietin receptor: biogenesis, dimerization, and intracellular signal transduction. Cold Spring Harbor Symp Quant Biol 60: 93-104.
Love DC, Hanover JA (2005). The hexosamine signaling pathway: deciphering the O-GlcNAc code. Sci STKE 2005: re13.
Matthews BW (1975). Comparison of the predicted and observed secondary structure of T4 phage lysozyme. Biochim Biophys Acta 405:442-451.
Medina L, Grove K, Haltiwanger RS (1998). SV40 large T antigen is modified with O-linked N-acetylglucosamine but not with other forms of glycosylation. Glycobiology 8: 383-391.
Meyer L, Deau B, Forejtnikova H, Dumenil D, Margottin-Goguet F, Lacombe C, Mayeux P, Verdier F (2007). beta-Trcp mediates ubiquitination and degradation of the erythropoietin receptor and controls cell proliferation. Blood 109: 5215-5222.
Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R (1997). Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76: 105-116.
Ngounou Wetie AG, Sokolowska I, Woods AG, Roy U, Deinhardt K, Darie CC (2014). Protein-protein interactions: switch from classical methods to proteomics and bioinformatics-based approaches. CMLS 71: 205-228.
Nielsen H, Brunak S, von Heijne G (1999). Machine learning approaches for the prediction of signal peptides and other protein sorting signals. Protein Eng 12: 3-9.
Noguchi CT, Wang L, Rogers HM, Teng R, Jia Y (2008). Survival and proliferative roles of erythropoietin beyond the erythroid lineage. Expert Rev Mol Med 10: e36.
Parsa CJ, Kim J, Riel RU, Pascal LS, Thompson RB, Petrofski JA, Matsumoto A, Stamler JS, Koch WJ (2004). Cardioprotective effects of erythropoietin in the reperfused ischemic heart: a potential role for cardiac fibroblasts. J Biol Chem 279: 20655- 20662.
Sawyer ST, Penta K (1996). Association of JAK2 and STAT5 with erythropoietin receptors. Role of receptor phosphorylation in erythropoietin signal transduction. J Biol Chem 271: 32430- 32437.
Sugawa M, Sakurai Y, Ishikawa-Ieda Y, Suzuki H, Asou H (2002). Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation. Neurosci Res 44: 391-403.
Sulahian R, Cleaver O, Huang LJ (2009). Ligand-induced EpoR internalization is mediated by JAK2 and p85 and is impaired by mutations responsible for primary familial and congenital polycythemia. Blood 113: 5287-5297.
Thanka Christlet TH, Veluraja K (2001). Database analysis of O-glycosylation sites in proteins. Biophys J 80: 952-960.
Thompson JD, Higgins DG, Gibson TJ (1994). CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680.
Tyson JJ, Chen K, Novak B (2001). Network dynamics and cell physiology. Nat Rev Mol Cell Biol 2: 908-916.
von Lindern M, Parren-van Amelsvoort M, van Dijk T, Deiner E, van den Akker E, van Emst-de Vries S, Willems P, Beug H, Lowenberg B (2000). Protein kinase C alpha controls erythropoietin receptor signaling. J Biol Chem 275: 34719- 34727.
Walrafen P, Verdier F, Kadri Z, Chretien S, Lacombe C, Mayeux P (2005). Both proteasomes and lysosomes degrade the activated erythropoietin receptor. Blood 105: 600-608.
Wang L, Di L, Noguchi CT (2014). Erythropoietin, a novel versatile player regulating energy metabolism beyond the erythroid system. Int J Biol Sci10: 921-939.
Wang X, Li D, Wu G, Bazer FW (2016). Functional roles of fructose: Crosstalk between O-linked glycosylation and phosphorylation of Akt-TSC2-MTOR cell signaling cascade in ovine trophectoderm cells. Biol Reprod 95(5): 102.
Wells L, Kreppel LK, Comer FI, Wadzinski BE, Hart GW (2004). O-GlcNAc transferase is in a functional complex with protein phosphatase 1 catalytic subunits. J Biol Chem 279: 38466- 38470.
Wu H, Lee SH, Gao J, Liu X, Iruela-Arispe ML (1999). Inactivation of erythropoietin leads to defects in cardiac morphogenesis. Development 126: 3597-3605.
Yoon D, Watowich SS (2003). Hematopoietic cell survival signals are elicited through non-tyrosine-containing sequences in the membrane-proximal region of the erythropoietin receptor (EPOR) by a Stat5-dependent pathway. Exp Hematol 31: 1310- 1316.